Psychiatric symptoms during isotretinoin therapy;Psychiatrische verschijnselen bij gebruik van isotretinoïne

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 47, 2003, Pages 2341-2343

  Van Broekhoven, F ^a   Verkes, R J ^a   Janzing, J G E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE CONGLOBATA; ADULT; ARTICLE; BIPOLAR DISORDER; CASE REPORT; DEPRESSION; DISEASE EXACERBATION; HOSPITAL ADMISSION; HUMAN; LITERATURE; MALE; MENTAL DISEASE; SUICIDAL BEHAVIOR;

ACNE VULGARIS; ADULT; DEPRESSION; DERMATOLOGIC AGENTS; FATAL OUTCOME; HUMANS; ISOTRETINOIN; MALE; SUICIDE;

EID: 0344443819     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;45:515-9.
2. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846-50.
3. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression, and isotretinoin. J Am Acad Dermatol 2001;45:S168-75.
4. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987;17:25-32.
5. Strom BL. Pharmacoepidemiology. Chichester: John Wiley; 2000.
6. Wysowski DK, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. N Engl J Med 2001;344:460.
7. Bruno NP, Beacham BE, Burnett JW. Adverse effects of isotretinoin therapy. Cutis 1984;33:484-6, 489.
8. Sporn MB, Roberts AB, Goodman DS. The retinoids: biology, chemistry, and medicine. New York: Raven Press; 1994.
9. Goodman AB. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA 1998;95:7240-4.
10. Werme M, Ringholm A, Olson L, Brene S. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine. Brain Res 2000;863:112-9.
11. Citver AS, Shields AM, Ciaccia LM, Schulingkamp RJ, Raffa RB. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia. J Clin Pharm Ther 2002;27:161-8.
12. Watson DG, Wainer BH, Lenox RH. Phorbol ester- and retinoic acid-induced regulation of the protein kinase C substrate MARCKS in immortalized hippocampal cells. J Neurochem 1994;63:1666-74.
13. Hersom K, Neary MP, Levaux HP, Klaskala W, Strauss JS. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. J Am Acad Dermatol 2003;49:424-32.
14. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000;136:1231-6.
15. Wysowski DK, Beitz J. Methodological limitations of the study 'Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide'. Arch Dermatol 2001;137:1102-3.
16. Middelkoop T. Roaccutane (isotretinoin) and the risk of suicide. J Pharm Pract 1999;12:374-8.
17. Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, et al. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol 2001;45:196-207.
18. Ng CH, Tam MM, Celi E, Tate B, Schweitzer I. Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australas J Dermatol 2002;43:262-8.
19. Gatti S, Serri F. Acute depression from isotretinoin. J Am Acad Dermatol 1991;25:132.
20. Ng CH, Schweitzer I. The association between depression and isotretinoin use in acne. Aust N Z J Psychiatry 2003;37:78-84.
21. Stricker BHCh. Geneesmiddelenbewaking: over spookschepen en Russische roulette. Ned Tijdschr Geneeskd 2002;146:1258-61.